Hemoglobin and Iron Metabolism — MCQs

Hemoglobin and Iron Metabolism Indian Medical PG Practice Questions and MCQs

Question 131: In sickle cell anemia, sickle shapes occur due to the polymerization of what?

A. Oxyhemoglobin
B. Deoxyhemoglobin (Correct Answer)
C. Methoxyhemoglobin
D. Cyanhemoglobin

Explanation: **Explanation:** Sickle cell anemia is caused by a point mutation in the $\beta$-globin gene, where **glutamic acid** (polar) is replaced by **valine** (non-polar) at the **6th position**. This substitution creates a "hydrophobic patch" on the surface of the hemoglobin molecule (HbS). **Why Deoxyhemoglobin is correct:** The polymerization of HbS is strictly dependent on the conformational state of the molecule. In the **deoxygenated state (T-state)**, the hydrophobic valine residue at position 6 of one $\beta$-chain fits into a complementary hydrophobic pocket on a neighboring HbS molecule. This leads to the formation of long, insoluble fibrous polymers that distort the red blood cell into a crescent or "sickle" shape. This process is reversible upon re-oxygenation but becomes permanent after repeated cycles. **Why other options are incorrect:** * **Oxyhemoglobin (R-state):** When hemoglobin is oxygenated, the conformational change hides the hydrophobic pocket. Therefore, HbS does not polymerize in its oxygenated form. * **Methemoglobin (Methoxyhemoglobin):** This refers to hemoglobin where iron is in the ferric ($Fe^{3+}$) state. While it cannot carry oxygen, it does not possess the specific structural orientation required for the valine-mediated stacking seen in sickle cell disease. * **Cyanhemoglobin:** This is a stable compound formed when cyanide binds to methemoglobin. It is irrelevant to the pathophysiology of sickling. **NEET-PG High-Yield Pearls:** * **Mutation:** Missense mutation (GAG $\rightarrow$ GTG). * **Factors promoting sickling:** Hypoxia, acidosis (Bohr effect), dehydration, and increased 2,3-BPG—all of which shift the curve to the right and stabilize the **Deoxy** state. * **Diagnosis:** HPLC is the gold standard; Sickling test (using Sodium metabisulfite) and Solubility test are screening methods. * **Protective factor:** HbF (Fetal hemoglobin) inhibits polymerization, which is why symptoms appear only after 6 months of age and why **Hydroxyurea** (which increases HbF) is used in treatment.

Question 132: What is the normal total iron-binding capacity (TIBC)?

A. 0.5-1 mg/litre
B. 1.5-2.5 mg/litre
C. 1.0-1.5 mg/litre
D. None of the above (Correct Answer)

Explanation: **Explanation:** The correct answer is **None of the above** because the values provided in options A, B, and C are significantly lower than the physiological range for Total Iron-Binding Capacity (TIBC). **1. Understanding TIBC:** TIBC is a clinical measure of the blood's capacity to bind iron with transferrin. Since transferrin is the primary iron-transport protein, TIBC is an indirect measurement of the transferrin concentration in the serum. The normal reference range for TIBC in a healthy adult is approximately **250–450 µg/dL** (which equates to **2.5–4.5 mg/L**). **2. Analysis of Options:** * **Options A, B, and C:** These values (0.5–2.5 mg/L) are far below the normal physiological range. Even in states of severe protein deficiency or iron overload (where TIBC decreases), the levels rarely drop to the ranges suggested in these options. * **Option D:** This is correct because the standard clinical range (2.5–4.5 mg/L) is not represented. **3. Clinical Pearls for NEET-PG:** * **Transferrin Saturation:** Normally, only about **1/3 (33%)** of transferrin binding sites are saturated with iron. * **Iron Deficiency Anemia (IDA):** Characterized by **High TIBC** (the body produces more transferrin to "hunt" for iron) and Low Serum Iron. * **Anemia of Chronic Disease (ACD):** Characterized by **Low TIBC** (or normal) and Low Serum Iron, as iron is sequestered in macrophages. * **Hemochromatosis:** Characterized by **Low TIBC** and High Serum Iron/Ferritin. * **Formula:** $TIBC (\mu g/dL) \approx Serum\ Transferrin\ (mg/dL) \times 1.25$.

Question 133: What is the formula used for the estimation of the total iron requirement?

A. 4 x body weight (kg) x Hb deficit (g/dL)
B. 4.4 x body weight (kg) x Hb deficit (g/dL) (Correct Answer)
C. 0.3 x body weight (kg) x Hb deficit (g/dL)
D. 3.3 x body weight (kg) x Hb deficit (g/dL)

Explanation: The estimation of total iron requirement is calculated using the **Ganzoni Formula**. This formula is clinically essential for determining the dose of parenteral iron needed to restore a patient's hemoglobin levels and replenish iron stores. ### **Explanation of the Correct Answer** **Option B (4.4 x body weight x Hb deficit)** is the simplified version of the Ganzoni Formula. The derivation is as follows: * **Total Iron Deficit (mg)** = Body weight (kg) × (Target Hb - Actual Hb) (g/dL) × 2.4 + Iron stores (mg). * The factor **2.4** accounts for the iron content of hemoglobin (0.34%) and blood volume (approx. 7% of body weight). * To account for **iron stores** (usually 500 mg for adults), the simplified multiplier of **4.4** is often used in clinical practice to provide a quick estimation that covers both the hemoglobin deficit and the replenishment of depleted stores. ### **Analysis of Incorrect Options** * **Option A & D:** These values (4 and 3.3) are mathematically incorrect and do not align with the physiological constants of iron concentration in hemoglobin or the standard Ganzoni calculation. * **Option C (0.3 x body weight x Hb deficit):** This is a common distractor. While 0.3 is used in some older pediatric formulas or specific calculations for iron per pound of body weight, it does not represent the standard metric formula used in modern medical exams. ### **NEET-PG High-Yield Pearls** * **Iron Content of Hb:** 1 gram of Hemoglobin contains approximately **3.34 mg** of elemental iron. * **Storage Iron:** In a healthy adult, iron stores (ferritin/hemosiderin) are approximately **500–1000 mg**. * **Oral vs. Parenteral:** The Ganzoni formula is specifically used to calculate the dose for **Intravenous (IV) iron** (e.g., Iron Sucrose or Ferric Carboxymaltose) when oral iron is ineffective or poorly tolerated. * **Target Hb:** Usually taken as 15 g/dL for calculation purposes.

Question 134: In HbM, what is the position of the point mutation?

A. Beta chain, 87th codon, Histidine - Tyrosine
B. Alpha chain, 87th codon, Histidine - Tyrosine (Correct Answer)
C. Beta chain, 6th codon, Glutamine - Valine
D. Beta chain, 6th codon, Glutamine - Lysine

Explanation: **Explanation:** **Hemoglobin M (HbM)** is a group of hemoglobin variants that result in **congenital methemoglobinemia**. The underlying mechanism involves a point mutation where the **proximal (F8)** or **distal (E7) histidine** residue is replaced by **Tyrosine**. 1. **Why Option B is correct:** In the alpha chain, the 87th amino acid is the proximal histidine (His F8). When this is mutated to Tyrosine (His $\rightarrow$ Tyr), the phenolic group of tyrosine creates a stable bond with the ferric ($Fe^{3+}$) state of iron. This prevents the iron from being reduced back to the ferrous ($Fe^{2+}$) state, rendering the hemoglobin incapable of binding oxygen, leading to cyanosis. 2. **Analysis of Incorrect Options:** * **Option A:** While a mutation at the 92nd position of the Beta chain (His $\rightarrow$ Tyr) also causes HbM (HbM Saskatoon), the 87th position specifically refers to the Alpha chain (HbM Iwate). * **Option C:** This describes **HbS (Sickle Cell Anemia)**, where Glutamic acid is replaced by Valine at the 6th position of the Beta chain. * **Option D:** This describes **HbC**, where Glutamic acid is replaced by Lysine at the 6th position of the Beta chain. **High-Yield Clinical Pearls for NEET-PG:** * **HbM Variants:** Common types include HbM Iwate ($\alpha$87 His$\rightarrow$Tyr) and HbM Boston ($\alpha$58 His$\rightarrow$Tyr). * **Clinical Presentation:** Patients present with "chocolate cyanosis" but are usually asymptomatic as the body compensates. * **Diagnosis:** HbM does not respond to Methylene blue (unlike acquired methemoglobinemia caused by NADH-cytochrome b5 reductase deficiency). * **Inheritance:** HbM follows an **Autosomal Dominant** pattern.

Question 135: The type of hemoglobin that has the least affinity for 2,3-Diphosphoglycerate (2,3-DPG) is:

A. Hemoglobin A
B. Hemoglobin F (Correct Answer)
C. Hemoglobin B
D. Hemoglobin A2

Explanation: ### Explanation **1. Why Hemoglobin F (HbF) is the Correct Answer:** The affinity of hemoglobin for 2,3-DPG depends on the presence of specific positively charged amino acids in the central cavity of the hemoglobin tetramer. * **Adult Hemoglobin (HbA)** consists of two alpha and two beta chains ($\alpha_2\beta_2$). The beta chains contain **Histidine** at the 143rd position, which creates a positive charge that binds the negatively charged 2,3-DPG. * **Fetal Hemoglobin (HbF)** consists of two alpha and two gamma chains ($\alpha_2\gamma_2$). In the gamma chain, the Histidine at position 143 is replaced by **Serine** (a neutral amino acid). This loss of positive charge reduces the binding affinity for 2,3-DPG. Since 2,3-DPG normally acts as an allosteric inhibitor that lowers oxygen affinity, its inability to bind HbF results in **HbF having a higher affinity for oxygen** than HbA. This is physiologically essential for the transfer of oxygen from maternal blood to the fetus across the placenta. **2. Why Other Options are Incorrect:** * **Hemoglobin A (HbA):** The primary adult hemoglobin ($\alpha_2\beta_2$). It binds 2,3-DPG strongly, shifting the oxygen dissociation curve to the right to facilitate oxygen unloading in tissues. * **Hemoglobin A2 (HbA2):** A minor adult hemoglobin ($\alpha_2\delta_2$). While it differs from HbA, it does not possess the specific structural modification (Serine substitution) that characterizes HbF's low affinity for 2,3-DPG. * **Hemoglobin B:** This is not a standard physiological hemoglobin variant relevant to this biochemical context. **3. High-Yield Clinical Pearls for NEET-PG:** * **Oxygen Dissociation Curve (ODC):** HbF causes a **Left Shift** in the ODC compared to HbA. * **2,3-DPG Function:** It stabilizes the **T-state** (Tense/Deoxygenated) of hemoglobin. * **Stored Blood:** Levels of 2,3-DPG decrease in stored blood, leading to increased oxygen affinity and potentially poor tissue oxygenation upon massive transfusion. * **High Altitude:** 2,3-DPG levels **increase** as a compensatory mechanism to favor oxygen unloading at the tissue level (Right shift).

Question 136: Ceruloplasmin has the activity of which of the following enzymes?

A. Hydrolase
B. Enolase
C. Aminotransferase
D. Ferroxidase (Correct Answer)

Explanation: **Explanation:** Ceruloplasmin is an $\alpha_2$-globulin synthesized in the liver that carries approximately 95% of the copper in plasma. Its primary enzymatic function is **Ferroxidase** activity. **Why Ferroxidase is correct:** For iron to be transported in the blood, it must bind to **transferrin**. However, transferrin can only bind iron in its **ferric state ($Fe^{3+}$)**. Iron absorbed from the gut or released from storage (ferritin) is typically in the **ferrous state ($Fe^{2+}$)**. Ceruloplasmin catalyzes the oxidation of $Fe^{2+}$ to $Fe^{3+}$, facilitating its binding to transferrin and subsequent transport to tissues like the bone marrow. **Why other options are incorrect:** * **Hydrolase:** These enzymes catalyze the cleavage of bonds (C-O, C-N, C-C) by the addition of water. Ceruloplasmin is a redox enzyme (oxidoreductase), not a hydrolase. * **Enolase:** This is a glycolytic enzyme that converts 2-phosphoglycerate to phosphoenolpyruvate. It is inhibited by fluoride. * **Aminotransferase:** These enzymes (like ALT and AST) catalyze the transfer of amino groups between amino acids and $\alpha$-keto acids, requiring Vitamin $B_6$ (Pyridoxal phosphate) as a cofactor. **High-Yield Clinical Pearls for NEET-PG:** * **Wilson’s Disease:** Characterized by a **deficiency of Ceruloplasmin** due to a defect in the ATP7B gene. This leads to copper deposition in the liver (cirrhosis), brain (basal ganglia), and eye (Kayser-Fleischer rings). * **Aceruloplasminemia:** A rare genetic disorder where the lack of ferroxidase activity leads to iron overload in tissues, despite normal dietary iron intake. * **Acute Phase Reactant:** Ceruloplasmin levels increase during inflammation, infection, or trauma.

Question 137: Transfer of iron from enterocyte to plasma is inhibited by?

A. Hepcidin (Correct Answer)
B. DMT-1
C. Ferroportin
D. Hephaestin

Explanation: ### Explanation **Correct Answer: A. Hepcidin** **Mechanism:** Iron absorption is primarily regulated at the basolateral membrane of the enterocyte. **Hepcidin**, a peptide hormone synthesized by the liver in response to high iron stores or inflammation, acts as the master regulator of iron homeostasis. It binds to **Ferroportin** (the only known cellular iron exporter) and triggers its internalization and lysosomal degradation. By removing Ferroportin from the cell surface, Hepcidin effectively blocks the transfer of iron from the enterocyte into the plasma, leading to iron sequestration within the cell. **Analysis of Incorrect Options:** * **B. DMT-1 (Divalent Metal Transporter 1):** This protein is located on the **apical** (luminal) membrane of the enterocyte. It is responsible for the *uptake* of inorganic non-heme iron from the intestinal lumen into the cell, not its transfer to plasma. * **C. Ferroportin:** This is the transport protein that *facilitates* the exit of iron from the enterocyte into the plasma. While it is the target of inhibition, Ferroportin itself promotes iron transfer. * **D. Hephaestin:** This is a copper-dependent ferroxidase that converts $Fe^{2+}$ to $Fe^{3+}$ at the basolateral membrane. This conversion is *necessary* for iron to bind to plasma transferrin; thus, it facilitates rather than inhibits transfer. **Clinical Pearls for NEET-PG:** * **Anemia of Chronic Disease:** Driven by high IL-6 levels which stimulate Hepcidin production, leading to low serum iron despite adequate stores (iron entrapment). * **Hemochromatosis:** Often caused by a deficiency in Hepcidin or its signaling, leading to uncontrolled ferroportin activity and iron overload. * **Ferroxidases:** Remember that **Hephaestin** works in the intestine, while **Ceruloplasmin** performs a similar ferroxidase function in the systemic circulation.

Question 138: Which of the following is a heme protein?

A. Hemoglobin
B. Catalase
C. Cytochrome
D. All of the above (Correct Answer)

Explanation: **Explanation:** A **heme protein** (or hemoprotein) is a specialized conjugated protein that contains a **heme prosthetic group**—a complex consisting of a porphyrin ring coordinated with a central iron atom (usually $Fe^{2+}$ or $Fe^{3+}$). These proteins perform diverse biological functions including oxygen transport, electron transfer, and enzymatic catalysis. * **Hemoglobin (Option A):** This is the most well-known heme protein. It consists of four globin chains, each containing a heme group. Its primary role is the reversible transport of oxygen from the lungs to peripheral tissues. * **Catalase (Option B):** This is a crucial antioxidant enzyme found in peroxisomes. It contains four heme groups and is responsible for neutralizing hydrogen peroxide ($H_2O_2$) into water and oxygen, protecting cells from oxidative damage. * **Cytochromes (Option C):** These are heme-containing proteins (e.g., Cytochrome c, Cytochrome P450) involved in electron transport. Cytochromes in the mitochondria facilitate the Electron Transport Chain (ETC) for ATP production, while Cytochrome P450 in the liver is vital for drug metabolism. Since all three options contain a heme moiety as their prosthetic group, **Option D** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** * **Myoglobin** is also a heme protein (monomeric) used for oxygen storage in muscles. * **Tryptophan pyrrolase** and **Nitric Oxide Synthase (NOS)** are other high-yield examples of heme-containing enzymes. * **Lead poisoning** inhibits Ferrochelatase and ALA dehydratase, disrupting heme synthesis. * **Carbon Monoxide (CO)** toxicity occurs because CO has a 200-250 times higher affinity for the heme iron in hemoglobin than oxygen.

Question 139: Hemoglobin Poland is best defined as

A. Alpha 2 : Delta 2
B. Alpha 2 : Epsilon 2
C. Zeta 2 : Gamma 2 (Correct Answer)
D. Zeta 2 : Epsilon 2

Explanation: **Explanation:** Hemoglobin synthesis during embryonic development involves a specific succession of globin chains. Before the transition to fetal hemoglobin (HbF: $\alpha_2\gamma_2$), the yolk sac produces "Embryonic Hemoglobins." These are composed of primitive alpha-like chains (**Zeta - $\zeta$**) and beta-like chains (**Epsilon - $\epsilon$** or **Gamma - $\gamma$**). **Hemoglobin Portland (Portland-1)** is specifically composed of **$\zeta_2\gamma_2$**. It is unique because it persists longer than other embryonic hemoglobins and is often detectable in neonates with $\alpha$-thalassemia major (Hb Bart’s hydrops fetalis), as the body attempts to compensate for the lack of $\alpha$-chain production. **Analysis of Options:** * **Option A ($\alpha_2\delta_2$):** This is **HbA2**, a minor adult hemoglobin (normal range: 1.5–3.5%). Elevated levels are a diagnostic marker for $\beta$-thalassemia trait. * **Option B ($\alpha_2\epsilon_2$):** This is **Hb Gower-2**, one of the three primary embryonic hemoglobins. * **Option D ($\zeta_2\epsilon_2$):** This is **Hb Gower-1**, the first hemoglobin to appear in the human embryo. **High-Yield Clinical Pearls for NEET-PG:** 1. **Embryonic Hemoglobins:** Remember the "Gower" and "Portland" series. * Gower 1: $\zeta_2\epsilon_2$ * Gower 2: $\alpha_2\epsilon_2$ * Portland: $\zeta_2\gamma_2$ 2. **Hb Portland-2:** A rarer variant composed of $\zeta_2\beta_2$. 3. **Developmental Switch:** $\zeta$ chains are replaced by $\alpha$ chains, and $\epsilon$ chains are replaced by $\gamma$ (fetal) then $\beta$ (adult) chains. 4. **Hb Bart’s ($\gamma_4$):** Found in Alpha-thalassemia (4-gene deletion); Hb Portland is the only functional hemoglobin often found alongside it in utero.

Question 140: Which of the following is the best indicator of iron deficiency?

A. Serum iron
B. Serum ferritin (Correct Answer)
C. Total Iron-Binding Capacity (TIBC)
D. Transferrin

Explanation: ### Explanation **Serum ferritin** is considered the **best and most sensitive initial indicator** of iron deficiency. Ferritin is the primary intracellular storage protein for iron. Serum ferritin levels are directly proportional to total body iron stores; therefore, a low serum ferritin level is highly specific for iron deficiency anemia (IDA), often decreasing before changes in hemoglobin or red cell morphology occur. **Why the other options are incorrect:** * **Serum iron:** This measures the amount of iron bound to transferrin in the blood. It is a poor indicator because it fluctuates significantly based on recent dietary intake, diurnal variation, and acute inflammation. * **Total Iron-Binding Capacity (TIBC):** This measures the blood's capacity to bind iron with transferrin. While TIBC **increases** in iron deficiency, it is an indirect measure and can be affected by liver function and nutritional status. * **Transferrin:** This is the transport protein for iron. While its levels increase in IDA, it is less specific than ferritin and is considered a "negative acute-phase reactant" (levels drop during inflammation). **High-Yield Clinical Pearls for NEET-PG:** * **The "Gold Standard":** While serum ferritin is the best *non-invasive* test, the absolute gold standard for assessing iron stores is a **Bone Marrow Aspiration** (Prussian blue staining), though it is rarely performed for simple IDA. * **The "Inflammation Caveat":** Ferritin is a **positive acute-phase reactant**. In the presence of infection, malignancy, or chronic inflammation, ferritin levels may appear "normal" or high even if the patient is iron deficient. * **Soluble Transferrin Receptor (sTfR):** This is a useful marker to distinguish IDA from Anemia of Chronic Disease (ACD), as sTfR levels rise in IDA but remain normal in ACD. * **Earliest Sign:** The very first biochemical sign of iron deficiency is a **decrease in serum ferritin**.

Practice by Chapter

Hemoglobin Structure and Function

Practice Questions

Oxygen Transport and Oxygen-Hemoglobin Dissociation Curve

Practice Questions

Hemoglobin Variants and Hemoglobinopathies

Practice Questions

Thalassemias

Practice Questions

Methemoglobin and Abnormal Hemoglobins

Practice Questions

Hemoglobin Synthesis

Practice Questions

Heme Synthesis and Porphyrias

Practice Questions

Iron Absorption and Transport

Practice Questions

Iron Storage and Recycling

Practice Questions

Disorders of Iron Metabolism

Practice Questions

Anemia: Biochemical Aspects

Practice Questions

Biochemistry of Hemostasis

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free